Drug profile · INN
collagenase clostridium histolyticum-aaes
QWO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
collagenase clostridium histolyticum-aaes (QWO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN collagenase clostridium histolyticum-aaes
Brand QWO
Route SUBCUTANEOUS
Formulation SOLUTION
Frequently asked questions
What is collagenase clostridium histolyticum-aaes?
collagenase clostridium histolyticum-aaes (QWO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for collagenase clostridium histolyticum-aaes?
QWO is a marketed brand name for collagenase clostridium histolyticum-aaes. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of collagenase clostridium histolyticum-aaes?
collagenase clostridium histolyticum-aaes has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.